Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Winsel

Showing results (21-30 of 53) with videos related to

Pageof 6
Sort By:
Die Pharmazie|April 1, 1985
[The pharmacokinetics of rifampicin in the intermittent treatment of patients with pulmonary tuberculosis. 2. The effect of rifampicin on the course of therapy for mycobacteriosis and non-tubercular infectious diseases]H Eule, E Werner, K Winsel, et al.
Tubercle|March 1, 1974
Intermittent chemotherapy of pulmonary tuberculosis using rifampicin and isoniazid for primary treatment: the influence of various factors on the frequency of side-effectsH Eule, E Werner, K Winsel, et al.
Die Pharmazie|January 1, 1976
[Separation, determination and pharmacokinestics of rifampicin and its biotransformation products]K Winsel, H Iwainsky, E Werner, et al.
Zeitschrift Fur Urologie Und Nephrologie|September 1, 1985
[Clinico-experimental studies of therapy optimization in kidney tuberculosis]H Köhler, K Winsel, H Iwainsky, et al.
Zeitschrift Fur Erkrankungen Der Atmungsorgane|January 1, 1978
[The lipids of the lungs in experimental aspiration pneumonitis (author's transl)]K Winsel, W Kuckelt, R Dauberschmidt, et al.
Die Pharmazie|November 1, 1986
[The effect of ambroxol and bromhexine on the "respiratory burst" of alveolar macrophages]K Winsel, H Grollmuss, U Unger, et al.
Scandinavian Journal of Respiratory Diseases|January 1, 1976
On the pharmacokinetics of rifampicin during treatment with intermittent administration. II. Influence of age and sex and of the patientsH Iwainsky, K Winsel, E Werner, et al.
Tubercle|March 1, 1974
Intermittent chemotherapy of pulmonary tuberculosis using rifampicin and isoniazed for primary treatment: the influence of various factors on the frequency of side-effectsH Eule, E Werner, K Winsel, et al.
Zeitschrift Fur Erkrankungen Der Atmungsorgane|January 1, 1985
[Bronchoalveolar lavage]H Iwainsky, K Winsel, H Grollmuss, et al.
Zeitschrift Fur Erkrankungen Der Atmungsorgane|January 1, 1985
[Modulation of alveolar macrophage activity by ambroxol, bromhexine and exogenous arachidonic acid]K Winsel, H Grollmuss, U Unger, et al.
Pageof 6

Showing results (21-30 of 53) with videos related to

Sort By:
Pageof 6
Die Pharmazie|April 1, 1985
[The pharmacokinetics of rifampicin in the intermittent treatment of patients with pulmonary tuberculosis. 2. The effect of rifampicin on the course of therapy for mycobacteriosis and non-tubercular infectious diseases]H Eule, E Werner, K Winsel, et al.
Tubercle|March 1, 1974
Intermittent chemotherapy of pulmonary tuberculosis using rifampicin and isoniazid for primary treatment: the influence of various factors on the frequency of side-effectsH Eule, E Werner, K Winsel, et al.
Die Pharmazie|January 1, 1976
[Separation, determination and pharmacokinestics of rifampicin and its biotransformation products]K Winsel, H Iwainsky, E Werner, et al.
Zeitschrift Fur Urologie Und Nephrologie|September 1, 1985
[Clinico-experimental studies of therapy optimization in kidney tuberculosis]H Köhler, K Winsel, H Iwainsky, et al.
Zeitschrift Fur Erkrankungen Der Atmungsorgane|January 1, 1978
[The lipids of the lungs in experimental aspiration pneumonitis (author's transl)]K Winsel, W Kuckelt, R Dauberschmidt, et al.
Die Pharmazie|November 1, 1986
[The effect of ambroxol and bromhexine on the "respiratory burst" of alveolar macrophages]K Winsel, H Grollmuss, U Unger, et al.
Scandinavian Journal of Respiratory Diseases|January 1, 1976
On the pharmacokinetics of rifampicin during treatment with intermittent administration. II. Influence of age and sex and of the patientsH Iwainsky, K Winsel, E Werner, et al.
Tubercle|March 1, 1974
Intermittent chemotherapy of pulmonary tuberculosis using rifampicin and isoniazed for primary treatment: the influence of various factors on the frequency of side-effectsH Eule, E Werner, K Winsel, et al.
Zeitschrift Fur Erkrankungen Der Atmungsorgane|January 1, 1985
[Bronchoalveolar lavage]H Iwainsky, K Winsel, H Grollmuss, et al.
Zeitschrift Fur Erkrankungen Der Atmungsorgane|January 1, 1985
[Modulation of alveolar macrophage activity by ambroxol, bromhexine and exogenous arachidonic acid]K Winsel, H Grollmuss, U Unger, et al.
Pageof 6